Related Experiment Videos
Major histocompatibility complex associations with systemic lupus erythematosus.
Z Fronek1, L A Timmerman, C A Alper
1Department of Microbiology and Immunology, Stanford University Medical Center, California.
The American Journal of Medicine
|December 23, 1988
Summary
This study identified specific human leukocyte antigen (HLA) variants associated with lupus nephritis, a severe form of systemic lupus erythematosus (SLE). These findings help pinpoint genetic factors contributing to SLE kidney disease.
Area of Science:
- Immunogenetics
- Rheumatology
- Genetics
Background:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease with varied clinical presentations.
- Identifying genetic susceptibility factors for specific SLE subsets, like lupus nephritis, is crucial for understanding disease pathogenesis.
- The Major Histocompatibility Complex (MHC) region is known to harbor genes influencing autoimmune diseases.
Purpose of the Study:
- To identify genetic markers associated with lupus nephritis within the MHC region.
- To compare genetic profiles of SLE patients with and without renal involvement.
- To investigate the role of specific human leukocyte antigen (HLA) alleles and complement component 4A (C4A) null alleles in SLE pathogenesis.
Main Methods:
- Analysis of MHC gene products using locus-specific and oligonucleotide probes.
- Genotyping for human leukocyte antigen (HLA) DQ-beta alleles.
- Detection and characterization of C4A null alleles and their association with HLA types.
- Sequencing of novel DQ-beta genes in SLE patients.
Main Results:
- Significant increase in HLA-DR2 and the rare HLA-DR2-DQw1.AZH allele in lupus nephritis patients (RR=8.3).
- C4A null alleles found in one-third of SLE patients, often linked to HLA-DR3 (gene deletion) or HLA-DR2 (regulatory defect).
- Significant decrease in HLA-DR4 in nephritis patients (RR=0.3).
- Discovery of a novel DQ-beta gene variant in SLE patients absent in the general population.
Conclusions:
- Specific HLA alleles, particularly HLA-DR2 and certain DQ-beta variants, are strongly associated with lupus nephritis.
- Genetic factors within the MHC region play a significant role in determining SLE clinical phenotypes, especially renal involvement.
- Further research into these identified genetic markers may lead to improved diagnostic tools and targeted therapies for SLE patients with kidney disease.